Den europeiske union - norsk - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Den europeiske union - norsk - EMA (European Medicines Agency)

gilead sciences ireland uc - cobicistat - hiv-infeksjoner - antivirale midler til systemisk bruk - tybost is indicated as a pharmacokinetic enhancer of atazanavir 300 mg once daily or darunavir 800 mg once daily as part of antiretroviral combination therapy in human immunodeficiency virus-1 (hiv-1) infected adults and adolescents aged 12 years and older:weighing at least 35 kg co‑administered with atazanavir orweighing at least 40 kg co‑administered with darunavir.

Norge - norsk - Statens legemiddelverk

pharmaxis europe limited - mannitol - inhalasjonspulver, hard kapsel - 20 mg / 40 mg / 10 mg / 0 mg / 5 mg

Norge - norsk - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - inhalasjonsaerosol, suspensjon - 50 mikrog/ dose

Norge - norsk - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - inhalasjonsaerosol, suspensjon - 125 mikrog/ dose

Norge - norsk - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - inhalasjonsaerosol, suspensjon - 250 mikrog/ dose

Norge - norsk - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - inhalasjonspulver, dosedispensert - 50 mikrog/ dose

Norge - norsk - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - inhalasjonspulver, dosedispensert - 100 mikrog/ dose

Norge - norsk - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - inhalasjonspulver, dosedispensert - 250 mikrog/ dose

Norge - norsk - Statens legemiddelverk

glaxosmithkline as - flutikasonpropionat - inhalasjonspulver, dosedispensert - 500 mikrog/ dose